Top companies in the space include: West Chester, Pa.-based DePuy Synthes; Plainsboro, N.J.-based Integra Lifesciences; Dublin, Ireland-based Medtronic; and Kalamzaoo, Mich.-based Stryker Corp.
Here are the top four market drivers:
1. More neurological disorder cases. About 12 percent of global deaths are the result of neurological disorders. In the United States, neurological disorders rank as the sixth leading cause of mortality, according to the CDC.
2. Technological advancements. Over the past 10 years, advances in neurosurgical navigation, neurostimulation and endovascular aortic repair have boosted clinical accuracy.
3. Demand for minimally invasive surgeries. The industry has seen a spike in MIS due to the associated lower complication rate. Open surgeries tend to slow recovery periods.
4. Awareness of innovative products. More surgeons and patients are aware of technological advancements for treating ruptured and unruptured aneurysm. Flow diversion devices, liquid embolics, stents and clot retrieval devices are becoming more desirable than pharmacological therapy and surgical clipping.
More articles on spine:
Dr. Randall Dryer earns spot in the Expert Network: 5 key points
Dr. Donald Gore highlighted in The Leading Physicians of the World: 5 highlights
21st Century Cures Act opens up doors for stem cell therapies
